Poster Presentation Tour in Basic & Laboratory Science; 6th September, 09:00-17:00, Poster Hall

P6 COMPARISON OF DIAGNOSTIC VALUES OF THE FOURTH GENERATION ANTI HCV TESTS (INNOTEST HCV AB IV, DIASOURCE ANTI HCV ELISA V 4.0) WITH THIRD GENERATION ANTI HCV TESTS, by Recep Kesli

P33 INVESTIGATION OF DIAGNOSTIC VALUES OF DIFFERENT ANTI HCV REACTIVES BASED ON IMMUNOASSAY METHOD USED IN THE LABORATORY DIAGNOSIS OF HEPATITIS C INFECTION IN TURKEY, by Recep Kesli

P37 IMPACT OF HOST GENE POLYMORPHISMS ON SUSCEPTIBILITY TO CHRONIC HEPATITIS B VIRUS INFECTION, by Bita Moudi

P38 CCR5, MCP-1 AND VDR GENE POLYMORPHISMS ARE ASSOCIATED WITH THE SUSCEPTIBILITY TO HBV INFECTION, by Bita Moudi

P39 THE RELATIONSHIP BETWEEN LAMC1 GENE POLYMORPHISM AND SUSCEPTIBILITY TO THE CHRONIC HEPATITIS B VIRUS INFECTION IN AN IRANIAN POPULATION, by Bita Moudi

P40 POLYMORPHISMS OF SURVIVIN GENE AND ITS PROTEIN EXPRESSION ARE ASSOCIATED WITH CHRONIC HBV INFECTION IN IRANIAN POPULATION, by Bita Moudi

P41 ASSOCIATION OF TNF-A GENE POLYMORPHISMS WITH THE OUTCOMES OF CHRONIC HEPATITIS B INFECTION IN IRANIAN POPULATION: LOOKING AT THE PROTEIN LEVEL, by Bita Moudi

P42 INTERFERON GAMMA GENE POLYMORPHISMS AND CHRONIC HEPATITIS B INFECTIONS IN AN IRANIAN POPULATION, by Bita Moudi

P57 A META-ANALYSIS FOR TUMOR NECROSIS FACTOR-A POLYMORPHISMS AND RISK OF HEPATOCELLULAR CARCINOMA, by Shahnaz Sali

P60 EFFECTS OF CURCUMIN ON NF-KB SIGNALING PATHWAY IN HEPATITIS B VIRUS INFECTION, by AmirReza Hesari

P61 MICRORNAS AND HEPATITIS C VIRUS: BIOMARKERS, FUNCTIONS AND THERAPY, by AmirReza Hesari

P62 NEW OPTIONS FOR CHRONIC HEPATITIS B VIRUS INFECTION TREATMENT: \” MANIPULATION OF REGULATORY CELLS’ RESPONSES \”, by Soheil Tavakolpour

P66 EVALUATION OF HBV RESISTANCE TO TENOFOVIR IN PATIENTS WITH CHRONIC HEPATITIS B USING ZNA PROBE ASSAY IN KERMAN, SOUTHEAST OF IRAN, by Hamid Reza Mollaei

P91 HAPLOTYPE ANALYSIS OF THE INTERLEUKIN-1 GENE CLUSTER POLYMORPHISM IN THE CHRONIC HEPATITIS B VIRUS INFECTION, by Bita Javan

P105 ABSENT OF HBV PROTECTIVE CCR5-DELTA32 MUTATION IN THE SOUTHERN KHORASAN POPULATION (EAST OF IRAN), by Hamidreza Safari

P117 ASSOCIATION OF IL-28B RS12979860 C/T AND RS8099917 T/G HAPLOTYPE WITH HEPATITIS C INFECTION OUTCOME IN IRAN: SPONTANEOUS CLEARANCE VERSUS CHRONIC INFECTION, by Jamal Sarvari

P122 APTAMERS AGAINST HEPATITIS C VIRUS: A REVIEW ARTICLE, by Amir Shamshirian

P123 COMBINED EVALUATION OF AFP, CA15-3, CA125 AND CA19-9 TUMOR MARKER IN PATIENTS WITH HEPATITIS B AND C, by Sara Yeganeh

P125 ANTI-CANCER EFFECTS OF ADMINISTRATION OF TILORONE DIHYDROCHLORIDE ON THE HEPA1-6, MOUSE HEPATOMA, CELL LINE, by Mahsa Alem

P130 RELATION BETWEEN IFN-Y POLYMORPHISM AND THE OUTCOME OF HEPATITIS B INFECTION IN AN IRANIAN POPULATION, by Mohammad Sadegh Naghizadeh

P139 VIRAL LOAD IS ASSOCIATED WITH SERUM ADENOSINE DEAMINASE AND ORNITHINE DECARBOXYLASE LEVEL IN PATIENTS WITH GENOTYPE 3A HEPATITIS C INFECTION, by Galia Amirbozorgi

P140 ASSOCIATION OF INTERLEUKIN 18 GENE SINGLE NUCLEOTIDE POLYMORPHISM (RS360719) WITH CHRONIC HEPATITIS B VIRUS INFECTION, by Haleh Sarrafnia

P160 DESIGN AND DEVELOPMENT OF A ONE STEP TAQMAN REAL TIME RT-PCR ASSAY TO QUANTIFY HEPATITIS C VIRUS RNA, by Fahimeh Ranjbar Kermani

P168 RESISTANT ASSOCIATED VARIANTS (RAVS) INVESTIGATION IN THE NAÏVE HCV PATIENTS, by Samira Salman-Tabar

P171 EFFECT OF SILICON DIOXIDE NANOPARTICLES ON LIVER CYSTATIN ISOLATED FROM BUFFALO KIDNEY: AN IMPLICATION FOR LIVER DISEASES, by Mohd Anas Shamsi

P172 MUTATION FREQUENCY OF THE SW172* MUTANTS AMONG IRANIAN CHRONIC HBV PATIENTS WHO PARTIALLY RESPONDED TO LAMIVUDINE PLUS ADEFOVIR DIPIVOXIL THERAPY, by Mostafa Mahabadi

P180 POTENTIAL OF PROBIOTICS AGAINST AFLATOXIN ABSORPTION IN CACO-2 CELLS, by Seyed Amir Behtash Ladan

P190 A NOVEL INDUCTIVE IMMUNOBIOSENSOR BASED ON MODIFIED MAGNETIC NANOPARTICLES FOR DETECTION OF HEPATITIS B SURFACE ANTIGEN, by Elias Alipour

P207 DEVELOPMENT OF AN ELECTROCHEMICAL IMMUNOSENSOR USING MAGNETIC BEADS FOR DETECTION OF HEPATITIS B SURFACE ANTIGEN, by Sara Nourani

P210 INVESTIGATION OF COVALLENT ATTACHMENTS BETWEEN STREPTAVIDIN AND ANTI- HEPATITIS B ANTIBODY USING DOCKING, by Mostafa Sourian

P215 ASSOCIATION STUDY ON HUMAN LEUKOCYTE ANTIGEN (HLA-DPB1) POLYMORPHISM RS1042151 IN IRANIAN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION, by Shahrzad Shoraka

P217 LACK OF ASSOCIATION BETWEEN INTERLEUKIN-21 GENE POLYMORPHISM (RS3117229) AND CHRONIC HEPATITIS C VIRUS INFECTION, by Shahrzad Shoraka

P218 ANALYSIS OF BASELINE RESISTANCE-ASSOCIATED VARIANTS (RAVS) IN HCV-INFECTED GENOTYPE 1A TREATMENT-EXPERIENCED PATIENTS, by Ali Namvar